News

The ALLG November Scientific Meeting 2019 wrapped up in Adelaide on November 15, having delivered an expanded forum for shaping the direction of blood cancer research across Australia and New Zealand.

The ALLG hosted a roundtable discussion yesterday in Melbourne, led by Professor Peter Borchmann of the University of Cologne and co-chairman of the German Hodgkin Study Group (GHSG).

ALLG will take part in Australia’s first Blood Cancer Taskforce, announced yesterday by Minister Greg Hunt and established in collaboration with the Leukaemia Foundation of Australia, which [...]

This week, ALLG’s National Blood Cancer Registry (NBCR) contributed to a new study on acute myeloid leukaemia (AML) published in the Journal of Clinical Oncology.

Cara Markovic joins the ALLG with over 15 years of experience in the medical device industry. A PhD qualified physiologist by training, she has held various scientific and marketing roles in [...]

As part of the EHA conference, Prof Harry Iland launched the APML5 interim clinical trial results, a comparative bioavailability study of oral sodium hydrogen diarsenic tetroxide and intravenous [...]

The Australasian Leukaemia and Lymphoma Group (ALLG) held its May 2019 Scientific Meeting (SM) in Sydney with over 300 members, associate members, professional staff and affiliated guests in [...]

On 21 March 2019, the ALLG in conjunction with the VCCC hosted ‘AML in 2019 and Beyond’ at Walter and Eliza Hall Institute of Medical Research.

Last year, the Liberal National Government announced that they will provide $38.6 million to support 23 new clinical trials to improve treatments and discover cures for debilitating and deadly [...]

Late last year, the ALLG appointed Marina Mullins in the role of ALLG Operations Manager. She manages both the programme of ALLG clinical trials, and the staff of the ALLG Trial Centre.

We are all extremely saddened to announce that internationally renowned and respected Professor Bertrand Coiffier passed away on 2 January 2019 at the age of 71.

This year, ALLG achieved an increase in the number and participation of clinical trials, an increase in member engagement, and improved site commitment to the trial program. Thank you to all the [...]